The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
A study found that residual myeloproliferative neoplasm clones persisted after hematopoietic cell transplantation in patients with myelofibrosis, and this information enabled researchers to
Andy Zeng, MD, PhD, of Princess Margaret Cancer Centre in Toronto, Canada, and colleagues presented the findings at the 2026 EHA Congress. The
Results from the MONUMENTAL-3 study showed that the combination of talquetamab and daratumumab with or without pomalidomide (Tal-DP/Tal-D) significantly improved survival compared with
In the largest cohort study of the rare HHV8-positive diffuse large B-cell lymphoma, researchers found that age ≥60 years, higher Charlson-Deyo score, HIV-positive
The retrospective, propensity score-matched cohort study used TiNetX electronic health record data to identify adult patients with hematologic malignancies receiving bispecific antibody therapy.
The study included adults with stage 2-4 HIV-related DLBCL who were treatment-naïve or had previously received one cycle of R-da-EPOCH or CHOP (cyclophosphamide,
Anthony Stein, MD, of the Gehr Family Center for Leukemia Research at City of Hope in California, and colleagues, conducted the single-center, open-label,
Researchers conducted a systematic review of phase III trials to assess the correlation between these two endpoints in MCL studies. The final analysis
The phase I/II study was conducted at 15 sites in the United States and Canada. A total of 30 adults with AML or
Pirtobrutinib resulted in an 82.5% objective response rate in patients with Waldenström macroglobulinemia, and the ORR was 81.0% in those who previously received
